Verena Hultsch

Company: Sanofi

Job title: Global Lead for BP, Dupilumab, Dermatology

Seminars:

Bullous Pemphigoid: Exploring New Frontiers 3:30 pm

Describe the heterogenous clinical presentations, disease burden, and diagnosis of bullous pemphigoid (BP) Highlight current understanding of BP pathophysiology and the critical role of autoimmunity and type 2 inflammation in both clinical signs and itch Discuss unmet needs from a clinical management perspective and how targeted therapies may address themRead more

day: Conference Day Two

Patient Recruitment in Rare Disease & Competitive Drug Development Landscapes: Enhancing Efficiency & Shortening Timelines to Clinical Development 3:30 pm

The dermatological drug development field is expanding fast, with a growing pipeline of therapies targeting disease, both high in prevalence, in addition to pathogenesis insights driving progress for rarer disease populations. With therapeutic breakthroughs for patients on the horizon, this workshop provides a crucial platform to address bottlenecks around recruitment, in order to meet needed…Read more

day: Pre-Conference Workshops